Adnec and ExCeL London are co-operating with the National Health Service of the UK and all relevant parties with the aim to provide all available necessary capabilities to facilitate medical teams, reported state news agency Wam.

In addition, Adnec and ExCeL London will provide all necessary technical and logistical support to sustain the functionality of the venue’s facilities in accordance with the highest global standards.

This co-operation is aligned with Adnec’s strategy, which aims to support all national and international initiatives that will mitigate the impact of the COVID-19, by providing the capabilities, facilities and infrastructure to the concerned authorities on all local and international levels.

NHS Nightingale Hospital will have a capacity of 4,000 beds and will be able to provide a comprehensive range of medical support facilities for those infected with COVID-19. The hospital shall contain two wards, each of which can hold 2,000 people.

ExCeL London is London’s largest international exhibition and convention centre and was acquired by Adnec is 2008. The venue includes London’s only International Convention Centre, ICC London which was opened in 2010 with funding by Adnec.

The NHS Nightingale Hospital is expected to open to patients next week, and will be immediately used to provide care to those suffering with severe symptoms of COVID-19. Both Adnec Group and ExCeL London are co-ordinating closely with the British health authorities to ensure the smooth establishment of the medical facility, alongside ensuring that medical practitioners are provided with as much support as required to facilitate the provision of care to patients.

Based in the London Docklands of the capital city of the UK, ExCeL London holds capacity for 70,000 people. The exhibition centre is one of Adnec’s portfolio of conference venues, alongside the Abu Dhabi National Exhibitions Centre in Abu Dhabi, and the Al Ain Convention Centre in Al Ain. – TradeArabia News Service

Copyright 2020 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.